FOLD FY 2023 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$399M+21.3% YoY

Gross Profit

$362M90.7% margin

Operating Income

-$77M-19.3% margin

Net Income

-$152M-38.0% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

-$69M

Free Cash Flow

-$77M

Stock-Based Comp.

$86M

Balance Sheet

Total Assets

$778M

Total Liabilities

$618M

Stockholders' Equity

$160M

Cash & Equivalents

$247M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$399M	$329M	+21.3%
Gross Profit	$362M	$291M	+24.6%
Operating Income	-$77M	-$212M	+63.6%
Net Income	-$152M	-$237M	+35.9%